Torthaí cuardaigh - Lisa Lundgren

  • 1 - 7 toradh as 7 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Securing tomorrow’s workforce: insights from a Danish survey on factors influencing junior doctors’ specialization in geriatric medicine

    Securing tomorrow’s workforce: insights from a Danish survey on factors influencing junior doctors’ specialization in geriatric medicine de réir Lene Holst Andersen, Eva‐Lisa Lundgren, Pernille Holm Ellegaard, Siri Aas Smedemark, Karen Andersen‐Ranberg

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Leveraging Citizen Science in a College Classroom to Build Interest and Efficacy for Science and the Environment

    Leveraging Citizen Science in a College Classroom to Build Interest and Efficacy for Science and the Environment de réir Haley E. Smith, Bradley C. Allf, Lincoln R. Larson, Sara Futch, Lisa Lundgren, Lara B. Pacifici, Caren B. Cooper

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Tuberculosis following PD-1 blockade for cancer immunotherapy

    Tuberculosis following PD-1 blockade for cancer immunotherapy de réir Daniel L. Barber, Shunsuke Sakai, Ragini R. Kudchadkar, Steven P. Fling, Tracey A. Day, Julie Vergara, David Ashkin, Jonathan Cheng, Lisa Lundgren, Vanessa Raabe, Colleen S. Kraft, Jorge J. Nieva, Martin A. Cheever, Paul Nghiem, Elad Sharon

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study

    Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study de réir Thomas S. Uldrick, Priscila Gonçalves, Maher Abdul‐Hay, Alisa J Claeys, Brinda Emu, Marc S. Ernstoff, Steven P. Fling, Lawrence Fong, Judith C. Kaiser, Andreanne M. Lacroix, Steve Y. Lee, Lisa Lundgren, Kathryn Lurain, Christopher Parsons, Sharavi Peeramsetti, Ramya Ramaswami, Elad Sharon, Mario Sznol, Chia-Ching Wang, Robert Yarchoan, Martin A. Cheever

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab

    Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab de réir Nicolás A. Giraldo, Peter Nguyen, Elizabeth L. Engle, Genevieve J. Kaunitz, Tricia R. Cottrell, Sneha Berry, Benjamin Green, Abha Soni, Jonathan D. Cuda, Julie E. Stein, Joel Sunshine, Farah Succaria, Haiying Xu, Aleksandra Ogurtsova, Ludmila Danilova, Candice D. Church, Natalie J. Miller, Steve Fling, Lisa Lundgren, Nirasha Ramchurren, Jennifer H. Yearley, Evan J. Lipson, Mac Cheever, Robert A. Anders, Paul Nghiem, Suzanne L. Topalian, Janis M. Taube

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

    PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma de réir Paul Nghiem, Shailender Bhatia, Evan J. Lipson, Ragini R. Kudchadkar, Natalie Miller, Lakshmanan Annamalai, Sneha Berry, Elliot Chartash, Adil Daud, Steven P. Fling, Philip Friedlander, Harriet M. Kluger, Holbrook E. Kohrt, Lisa Lundgren, Kim Margolin, Alan Mitchell, Thomas Olencki, Drew M. Pardoll, Sunil Reddy, Erica Shantha, William H. Sharfman, Elad Sharon, Lynn Shemanski, Michi M. Shinohara, Joel Sunshine, Janis M. Taube, John A. Thompson, Steven M. Townson, Jennifer H. Yearley, Suzanne L. Topalian, Martin A. Cheever

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy

    Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy de réir Paul Nghiem, Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl, Phillip Friedlander, Adil Daud, Harriet M. Kluger, Sunil Reddy, Brian C. Boulmay, Adam I. Riker, Melissa Burgess, Brent A. Hanks, Thomas Olencki, Kim Margolin, Lisa Lundgren, Abha Soni, Nirasha Ramchurren, Candice D. Church, Song Y. Park, Michi M. Shinohara, Bob Salim, Janis M. Taube, Steven Bird, Nageatte Ibrahim, Steven P. Fling, Blanca Homet Moreno, Elad Sharon, Martin A. Cheever, Suzanne L. Topalian

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: